Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

Apr 30, 2021

BUY
$1.27 - $3.42 $109,474 - $294,804
86,200 Added 42.05%
291,200 $89,000
Q4 2020

Jan 29, 2021

BUY
$0.94 - $1.89 $173,900 - $349,650
185,000 Added 925.0%
205,000 $46,000
Q3 2020

Nov 05, 2020

BUY
$1.5 - $9.38 $30,000 - $187,600
20,000 New
20,000 $6,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.22B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.